Financials
- Market Capitalization 231.68 M
- Employee 34
- Founded 2004
- CEO Christopher U. Missling Ph.D.
- Website www.anavex.com
- Headquarter New York, United States
- FIGI BBG000C9K8K4
- Industry 生物技术
总收入
净利润
每股基本收益(基本 EPS)
总债务
自由现金流
现金及现金等价物
市盈率
-7.74
市销率
70.17
Related tickers
| # | 姓名 | 价格 | 24小时 % | 7天 % | 一个月 % | 一年 % | 市值 | 最近7天 | |
|---|---|---|---|---|---|---|---|---|---|
| 3506 | ACIU AC Immune SA - Common Stock | 2.36 USD | -2.07% | -5.98% | 0.00% | +15.12% | 240.11 M USD | ||
| 3516 | FULC Fulcrum Therapeutics, Inc. - Common Stock | 3.56 USD | -0.84% | -4.56% | +2.01% | -54.71% | 237.21 M USD | ||
| 3535 | TARA Protara Therapeutics, Inc. - Common Stock | 4.12 USD | +0.73% | 0.00% | +7.57% | +29.97% | 231.56 M USD | ||
| 3553 | DTIL Precision BioSciences, Inc. - Common Stock | 8.81 USD | +2.68% | -3.40% | +39.84% | +97.98% | 227.32 M USD |